__timestamp | BeiGene, Ltd. | Zoetis Inc. |
---|---|---|
Wednesday, January 1, 2014 | 6930000 | 1643000000 |
Thursday, January 1, 2015 | 7311000 | 1532000000 |
Friday, January 1, 2016 | 20097000 | 1364000000 |
Sunday, January 1, 2017 | 62602000 | 1334000000 |
Monday, January 1, 2018 | 195385000 | 1484000000 |
Tuesday, January 1, 2019 | 388249000 | 1638000000 |
Wednesday, January 1, 2020 | 600176000 | 1726000000 |
Friday, January 1, 2021 | 990123000 | 2001000000 |
Saturday, January 1, 2022 | 1277852000 | 2009000000 |
Sunday, January 1, 2023 | 1504501000 | 2151000000 |
Monday, January 1, 2024 | 2318000000 |
Unleashing insights
In the ever-evolving landscape of the pharmaceutical industry, operational efficiency is key. This analysis of Selling, General, and Administrative (SG&A) expenses from 2014 to 2023 offers a fascinating glimpse into the financial strategies of Zoetis Inc. and BeiGene, Ltd. Over this period, Zoetis Inc., a leader in animal health, maintained a steady SG&A expense, averaging around $1.7 billion annually. In contrast, BeiGene, Ltd., a rising star in biotechnology, saw its SG&A expenses skyrocket by over 21,000%, from a modest $6.93 million in 2014 to a staggering $1.5 billion in 2023. This dramatic increase reflects BeiGene's aggressive expansion and investment in research and development. As these two companies continue to navigate the competitive pharmaceutical market, their SG&A trends offer valuable insights into their strategic priorities and operational efficiencies.
Merck & Co., Inc. vs BeiGene, Ltd.: SG&A Expense Trends
Breaking Down SG&A Expenses: Sanofi vs BeiGene, Ltd.
Who Optimizes SG&A Costs Better? Zoetis Inc. or Opthea Limited
Breaking Down SG&A Expenses: Zoetis Inc. vs Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Zoetis Inc. vs Perrigo Company plc Trends and Insights
Selling, General, and Administrative Costs: Zoetis Inc. vs Wave Life Sciences Ltd.
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Bio-Techne Corporation
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and TG Therapeutics, Inc.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Amneal Pharmaceuticals, Inc.
BeiGene, Ltd. or ImmunityBio, Inc.: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: BeiGene, Ltd. vs Agios Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of BeiGene, Ltd. and Evotec SE